ISSN: 0167-6997
eISSN: 1573-0646
CAS Zone: Medicine (Zone 3)
No
INVESTIGATIONAL NEW DRUGS
Abbr. INVEST NEW DRUG
·UNITED STATES
·Frequency Quarterly
·Avg. articles/yr 88 articles
2.7
Latest IF
2.70%
Self-citation
较易
Submission difficulty
Avg. 1.0 months
Review cycle
About Journal
INVESTIGATIONAL NEW DRUGS是一本专注于新药研发领域的国际学术期刊，ISSN号为0167-6997，由美国出版商Springer出版，出版地为美国，出版周期为双月刊。该期刊的影响因子根据最新数据约为2.5左右，属于非开放获取（非OA）期刊，并被SCI收录，在中科院分区中通常位于医学或药学领域的3区或4区。该杂志的发文特点主要集中在临床前和临床阶段的抗肿瘤药物研究，涵盖药物发现、药理学、毒理学及临床试验等领域，尤其关注创新药物的开发与评价。杂志的质量较高，审稿流程严格，但影响因子相对中等，可能存在投稿竞争激烈和发表周期较长的风险，适合从事新药研发的研究人员投稿。
IF Trend
Recent Articles
No recent articles from this journal
Journal Info
ISSN
0167-6997
Abbr.
INVEST NEW DRUG
Country/Region
UNITED STATES
Frequency
Quarterly
CAS Zone
Medicine (Zone 3)
Open Access
No
Research Area
Medicine - Pharmacy
Coverage
Science Citation Index
Sub-categories
ONCOLOGYOncology3区PHARMACOLOGY & PHARMACYPharmacy3区
Submission & Homepage
Homepage
Analysis Services
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
